Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 5:05 pm Purchase | 2023-03-30 | 13G | NanoString Technologies, Inc. NSTGQ | RA Capital Management, L.P. | 2,577,373 5.500% | 2,433,473 (+1691.09%) | Filing History |
| 2023-04-10 5:01 pm Purchase | 2023-04-06 | 13D | Climb Bio, Inc. CLYM | RA Capital Management, L.P. | 13,163,071 48.800% | 11,112 (+0.08%) | Filing History |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing History |
| 2023-03-30 5:08 pm Purchase | 2023-03-28 | 13G | GH Research PLC GHRS | RA Capital Management, L.P. | 5,561,118 10.700% | 662,745 (+13.53%) | Filing History |
| 2023-03-30 5:07 pm Purchase | 2023-03-28 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV | RA Capital Management, L.P. | 4,817,359 22.000% | 3,917 (+0.08%) | Filing History |
| 2023-03-30 5:02 pm Purchase | 2023-03-28 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 12,876,898 18.000% | 3,500,496 (+37.33%) | Filing History |
| 2023-03-29 5:14 pm Purchase | 2023-03-27 | 13D | DICE Therapeutics, Inc. DICE | RA Capital Management, L.P. | 7,660,615 16.100% | 811,704 (+11.85%) | Filing History |
| 2023-03-27 5:00 pm Purchase | 2023-03-15 | 13G | CureVac N.V. CVAC | RA Capital Management, L.P. | 12,245,955 5.500% | 12,245,955 (New Position) | Filing History |
| 2023-03-20 4:30 pm Purchase | 2023-03-10 | 13G | Orchard Therapeutics plc ORTX | RA Capital Management, L.P. | 18,564,300 9.990% | 18,564,300 (New Position) | Filing History |
| 2023-02-27 4:57 pm Purchase | 2023-02-23 | 13G | Bitwise MARA Option Income Strategy ETF IMRA | RA Capital Management, L.P. | 2,122,465 5.200% | 1,309,784 (+161.17%) | Filing History |
| 2023-02-24 4:30 pm Purchase | 2023-02-14 | 13D | Mineralys Therapeutics, Inc. MLYS | RA Capital Management, L.P. | 3,180,920 7.800% | 3,180,920 (New Position) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Third Harmonic Bio, Inc. THRD | RA Capital Management, L.P. | 534,687 1.300% | 534,687 (New Position) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Celcuity Inc. CELC | RA Capital Management, L.P. | 2,249,421 9.900% | 762,950 (+51.33%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 5,199,746 9.990% | 1,689,643 (+48.14%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | GH Research PLC GHRS | RA Capital Management, L.P. | 4,898,373 9.400% | 2,054,616 (+72.25%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Kinnate Biopharma Inc. KNTE | RA Capital Management, L.P. | 4,264,144 9.700% | 671,092 (+18.68%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 5,516,067 9.800% | 645,000 (+13.24%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ImmunoGen, Inc. IMGN | RA Capital Management, L.P. | 22,075,158 9.990% | -87,800 (-0.40%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | 5:01 Acquisition Corp. FVAM | RA Capital Management, L.P. | 0 0.000% | -750,000 (Position Closed) | Filing History |